Neurological Service Studies & Research Findings
Neurological Service Studies & Research Findings - Peter MacCallum Cancer Centre
|Strong links have been developed with the Trans-Tasman Radiation Oncology Group (TROG) and more recently with the European Organisation for Research and Treatment of Cancer (EORTC).|
|Major research studies include:|
|• Low grade glioma study – EORTC/TROG.|
• Hypofractionated radiotherapy for elderly patients with high grade glioma incorporating functional imaging (under development) – TROG.
• Phase II study of temozolmide and caelyx for newly diagnosed glioblstoma mulitforme-Victorian Cooperative Oncology Group (VCOG)
• Ciliengitide for subjecs with newly diagnosed glioblastoma mulitforme and methylated MGMT.
• Gene promoter – a mulitcentre, open-label, controlled phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment along (under development) – EORTC/RMH.